Article information
Full text is only aviable in PDF
Bibliografía
[1.]
W. Weiss.
COPD and lung cancer.
Chronic obstructive pulmonary disease, pp. 344-347
[2.]
S. Romero Candeira, J. Picher Núñez, L. Otero Ochoa, E. Delgado Pérez, A. Izquierdo del Amo.
Aspectos funcionales en el carcinoma broncogénico.
Rev Clin Esp, 161 (1981), pp. 319-322
[3.]
J.M. Samet, C.G. Humble, D.R. Pathak.
Personal and family history of respiratory disease and lung cancer risk.
Am Rev Respir Dis, 134 (1986), pp. 466-470
[4.]
D.M. Skillrud, K.P. Offord, R.D. Miller.
Higher risk of lung cancer in chronic obstructive pulmonary disease. A prospective, matched, controlled study.
Ann Intern Med, 105 (1986), pp. 503-507
[5.]
M.S. Tockman, N.R. Anthonisen, E.C. Wright, M.G. Donthan.
the Intermitent Positive Pressure Breathing Trial Group, and the Johns Hopkins Lung Project for the early detection of lung cancer. Airways obstruction and the risk of lung cancer.
Ann Intern Med, 106 (1987), pp. 512-518
[6.]
A.H. Wu, M.C. Yu, D.C. Thomas, M.C. Pike, B.E. Henderson.
Personal and family history of lung disease as risk factors for adenocarcinoma of the lung.
Cancer Res, 48 (1988), pp. 7279-7284
[7.]
J. Sánchez de Cos Escuín, J. Redondo Antequera, A. Sever Redondo, A. García Lario, J.L. De la Cruz Ríos, F. Masa Jiménez.
Carcinoma broncopulmonar. Estudio epidemiológico-clínico de 157 casos.
Aten Primaria, 6 (1989), pp. 304-311
[8.]
A. Díez Herranz.
La cirugía en el tratamiento del carcinoma broncopulmonar extendido a los ganglios mediastínicos [Tesina de licenciatura] Valladolid, (1989),
[9.]
P. Lange, J. Nyboe, M. Appleyard, G. Jensen, P. Schnohr.
Ventilatory function and chronic mucus hypersecretion as predictors of death from lung cancer.
Am Rev Respir Dis, 141 (1990), pp. 613-617
[10.]
K.E. Osann.
Lung cancer in women: the importance of smoking, family history of cancer, and medical history of respiratory disease.
Cancer Res, 51 (1991), pp. 4893-4897
[11.]
M.C.R. Alavanja, R.C. Brownson, J.r. Boice JD, E. Hock.
Pre-existing lung disease and lung cancer among nonsmoking women.
Am J Epidemiol, 136 (1992), pp. 623-632
[12.]
A. Michils, J.C. Yernault, E. Noel, B. Gossart, G. Servais, J. Duchateau.
Abnormal humoral immune response to mucosal antigenic stimulation in patients with lung cancer.
Cancer, 69 (1992), pp. 2252-2257
[13.]
V. Dangubic, M. Ninkovic, D. Popovic, I. Tomic, B. Ciric, M. Dautovic.
The obstruction syndrome in patients with bronchogenic carcinoma [resumen].
Vojnosanit Pregl, 50 (1993), pp. 21-25
[14.]
J.J. Bechtel, W.R. Kelley, T.L. Petty, D.S. Patz, G. Saccomanno.
Outcome of 51 patients with roentgenographically occult lung cancer detected by sputum cytologic testing: a community hospital program.
Arch Intern Med, 154 (1994), pp. 975-980
[15.]
A.H. Wu, E.T.H. Fontham, P. Reynolds, R.S. Greenberg, P. Buffer, J. Liff, et al.
Previous lung disease and risk of lung cancer among lifetime nonsmoking women in the United States.
Am J Epidemiol, 141 (1995), pp. 1023-1032
[16.]
J. Congleton, M.F. Muers.
The incidence of airflow obstruction in bronchogenic carcinoma, its relation to breathlessness, and response to bronchodilator therapy.
Respir Med, 89 (1995), pp. 291-296
[17.]
M.L.G. Janssen-Heijnen, R.M. Schipper, P.P.A. Razenberg, M.A. Crommelin, J.-.W.W. Coebergh.
Prevalence and co-morbidity in lung cancer patients and its relationship with treatment: a population based study.
Lung Cancer, 21 (1998), pp. 105-113
[18.]
J.L. Aller Álvarez, J.F. De Frutos Arribas, A. Díez Herranz, F. Heras Gómez, J.M. Matilla González.
Comorbilidad.
Cordovilla Pérez, editores, por el Grupo de Estudio del Carcinoma Broncopulmonar de la SOCALPAR. El carcinoma broncopulmonar en la Comunidad de Castilla y León. Año 1997. Sociedad Castellano-Leonesa de Patología Respiratoria (SOCALPAR), pp. 81-88
[19.]
C. Anastasatu, H. Morgenstern, D. Burnea, M. Cristea, V. Mangiulea, L. Prutcanu.
Risk of bronchopulmonary cancer in patients with chronic obstructive bronchopneumopathy [resumen].
Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol, 31 (1982), pp. 211-218
[20.]
P. Harber, A. Oren, Z. Moshenifar, M. Lew.
Obstructive airways disease as a risk factor for asbestos-associated malignancy.
J Occup Med, 28 (1986), pp. 82-86
[21.]
R. Peto, F.E. Speizer, A.L. Cochrane, F. Moore, C.M. Fletcher, C.M. Tinker, et al.
The relevance in adults of air-flow obstruction, but no of mucus hypersecretion, to mortality from chronic lung disease. Results from 20 years of prospective observation.
Am Rev Respir Dis, 128 (1983), pp. 491-500
[22.]
L. Tenkanen, T. Hakulinen, L. Tejpo.
The joint effect of smoking and respiratory symptoms on risk of lung cancer.
Int J Epidemiol, 16 (1987), pp. 509-515
[23.]
L.H. Kuller, J. Ockene, E. Meilahn, K.H. Svendsen.
Relation of forced expiratory volume in one second (FEV1) to lung cancer mortality in the Multiple Risk Factor Intervention Trial (MRFIT).
Am J Epidemiol, 132 (1990), pp. 265-274
[24.]
A. Nomura, G.N. Stemmermann, P.H. Chyou, E.B. Marcus, A.S. Buist.
Prospective study of pulmonary function and lung cancer.
Am Rev Respir Dis, 144 (1991), pp. 307-311
[25.]
F.J. Wiles, E. Hnizdo.
Relevance of airflow obstruction and mucus hypersecretion to mortality.
Respir Med, 85 (1991), pp. 27-35
[26.]
J. Vestbo, K.M. Knudsen, F.C. Rasmussen.
Are respiratory symptoms and chronic airflow limitation really associated with an increased risk of respiratory cancer?.
Int J Epidemiol, 20 (1991), pp. 375-378
[27.]
S.K. Van den Eeden, G.D. Friedman.
Forced expiratory volume (1 second) and lung cancer incidence and mortality.
Epidemiology, 3 (1992), pp. 253-257
[28.]
N. Chau, L. Benamghar, Q.T. Pham, D. Teculescu, E. Rebstock, J.M. Mur.
Mortality of iron miners in Lorraine (France): relations between lung function and respiratory symptoms and subsequent mortality [resumen].
Br J Ind Med, 50 (1993), pp. 1017-1131
[29.]
P. Carta, P. Cocco, G. Picchiri.
Lung cancer mortality and airways obstruction among metal miners exposed to silica and low levels of radon daughters.
Am J Ind Med, 25 (1994), pp. 489-506
[30.]
S.S. Islam, D. Schottenfeld.
Declining FEV1 and chronic productive cough in cigarette smokers: a 25-year prospective study of lung cancer incidence in Tecumseh, Michigan.
Cancer Epidemiol Biomarkers Prev, 3 (1994), pp. 289-298
[31.]
N.R. Anthonisen, J.E. Connett, J.P. Kiley, M.D. Altose, W.C. Bailey, A.S. Buist, et al.
for the Lung Health Study Research Group. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study.
Jama, 272 (1994), pp. 1497-1505
[32.]
T.L. Petty.
Lung cancer and chronic obstructive pulmonary disease.
Med Clin North Am, 80 (1996), pp. 645-655
[33.]
T.L. Petty.
The predictive value of spirometry. Identifying patients at risk for lung cancer in the primary care setting.
Postgrad Med, 101 (1997), pp. 128-140
[34.]
G. Assennato, G. Ferri.
Correlazione fra broncopneumopatie croniche e carcinoma del polmone.
Arch Monaldi, 44 (1989), pp. 689-692
[35.]
O. Menard, B. Dousset, B. Jacob, D. Anthoine, Y. Martinet.
Signification des taux d'antigène carcino-embryonnaire dans le liquide de lavage alvéolaire en pathologie bronchopulmonaire cancéreuse et non cancéreuse.
Rev Mal Resp, 9 (1992), pp. 185-189
[36.]
C.M. Sanguinetti, G. Riccioni, F. Marchesani, R. Pela, L. Cecarini.
Bronchoalveolar lavage fluid level of carcynoembryonic antigen in the diagnosis of peripheral lung cancer.
Monaldi Arch Chest Dis, 50 (1995), pp. 177-182
[37.]
D. Anderson, J.A. Hughes, A. Cebulska-Wasilewska, E. Nizankowska, B. Graca.
Ras p21 protein levels in human plasma from patients with chronic obstructive pulmonary disease (COPD) compared with lung cancer patients and healthy controls.
Mutat Res, 403 (1998), pp. 229-235
[38.]
B.H. Cohen, C.G. graves, P. Kreiss, D.A. Levy, H.A. Menkes, S. Pernutt.
A common familial component in lung cancer and chronic obstructive pulmonary disease.
Lancet, ii (1977), pp. 523-526
[39.]
M.J. Khoury, T.H. Beaty, C.A. Newill, S. Bryant, B.H. Cohen.
Geneticenvironmental interactions in chronic airways obstruction.
Int J Epidemiol, 15 (1986), pp. 64-71
[40.]
M. Saetta, S. Baraldo, L. Corbino, G. Turato, F. Braccioni, F. Rea, et al.
CD8+ve cells in the lungs of smokers with chronic obstructive pulmonary disease.
Am J Respir Crit Care Med, 160 (1999), pp. 711-717
[41.]
M. Saetta, A. Di Stefano, G. Turato, F.M. Facchini, L. Corbino, C.E. Mapp, et al.
CD8+ T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease.
Am J Respir Crit Care Med, 157 (1998), pp. 822-826
[42.]
A. Díez Herranz.
Significado pronóstico de las pruebas inmunológicas en la cirugía del cáncer de pulmón [Tesis doctoral].
Universidad de Valladolid, (1994),
[43.]
B.N. Zyrianov, V.D. Podoplekin, V.S. Siianov, T.I. Kuznetsova, S.A. Tuzikov.
The determination of the level of antibodies to Epstein- Barr virus antigens in organizing groups at high risk for lung cancer disease [resumen].
Vopr Onkol, 36 (1990), pp. 545-549
[44.]
A. Palacios, R. Escó, C.J. Galán, J.J. Sanz, A. Castillo, F. Marín.
Sintomatología inicial y tiempo de diagnóstico del cáncer de pulmón.
Aten Primaria, 3 (1986), pp. 211-213
[45.]
T. Ringbaek, S. Borgeskov, P. Lange, K. Viskum.
Diagnostic and therapeutic process and prognosis in suspected lung cancer.
Scand Cardiovasc J, 33 (1999), pp. 337-343
[46.]
S.G. Spiro, H.H. Hansen.
Early detection: screening.
Lung tumors. Lung, mediastinum, pleura, and chest wall, pp. 9-11
[47.]
C.T. Bolliger, K. Haeussinger.
Early detection of lung cancer.
Eur Respir Mon, 9 (1998), pp. 22-35
[48.]
R.S. Fontana, D.R. Sanderson, L.W. Woolner, W.F. Taylor, W.E. Miller, J.E. Mulim, et al.
Screening for lung cancer. A critique of the Mayo Lung Project.
Cancer, 67 (1991), pp. 1155-1164
[50.]
E.-.R. Salomaa, K. Liippo, P. Taylor, J. Palmgren, J. Haapakoski, J. Virtano, et al.
Prognosis of patients with lung cancer found in a single chest radiograph screening.
Chest, 114 (1998), pp. 1514-1518
[51.]
G.M. Strauss, R.E. Gleason, D.J. Sugarbaker.
Chest X-ray screening improves outcome in lung cancer. A reappraisal of randomized trials on lung cancer screening.
Chest, 107 (1995), pp. S270-S279
[52.]
G.M. Strauss, R.E. Gleason, D.J. Sugarbaker.
Screening for lung cancer. Another look; a different view.
Chest, 111 (1997), pp. 754-768
[53.]
G.M. Strauss.
Measuring effectiveness of lung cancer screening. From consensus to controversy and back.
Chest, 112 (1997), pp. S216-S228
[54.]
B.J. Flehinger, M. Kimmel, T. Pulyak, M.R. Melamed.
Screening of lung cancer – The Mayo Project revisited.
Cancer, 72 (1993), pp. 1573-1580
[56.]
J.L. Mulshine, F. Scott.
Molecular markers in early cancer detection. New screening tools.
Chest, 107 (1995), pp. S280-S286
[58.]
Skillrud DM COPD: causes, treatment, and risk for lung cancer.
Compr Ther, 12 (1986), pp. 13-16
[59.]
J. Vestbo, P. Lange.
Forced expiratory volume in 1 second (FEV1) – A respiratory physiological measurement of considerable prognostic value [resumen].
Ugeskr Laeger, 153 (1991), pp. 2292-2295
[60.]
G.T. Ferguson, P.L. Enright, A.S. Buist, M.W. Higgins.
Office spirometry for lung health assessment in adults. A consensus statement from the National Health Education Program.
Chest, 117 (2000), pp. 1146-1161
[62.]
A. Böcking, S. Biesterfeld, R. Chatelain, G. Gien Gerlach, E. Esser.
Diagnosis of bronchial carcinoma on sections of paraffin-embedded sputum. Sensitivity and specificity of an alternative to routine cytology.
Acta Cytol, 36 (1992), pp. 37-47
[63.]
J.J. Bechtel, W.R. Kelley, T.L. Petty, D.S. Patz, G. Saccomanno.
Outcome of 51 patients with roentgenographically occult lung cancer detected by sputum cytologic testing: a community hospital program.
Arch Intern Med, 154 (1994), pp. 975-980
[64.]
T.C. Kennedy, Y. Miller, S. Prindiville.
Screening for lung cancer revisited and the role of sputum cytology and fluorescence bronchoscopy in a high-risk group.
Chest, 117 (2000), pp. S72-S79
[66.]
L. Callol Sánchez, F.J. Gómez de Terreros y Sánchez.
Diagnóstico precoz del cáncer de pulmón.
Arch Bronconeumol, 35 (1999), pp. 395-403
[67.]
M.S. Tockman.
Advances in early detection of lung cancer.
Semin Respir Crit Care Med, 17 (1996), pp. 335-341
[68.]
J. Tredaniel, I. Stucker, I. Migaud, A. Hirsch.
Depistage du cancer bronchique. Realites et perspectives.
Rev Mal Respir, 8 (1991), pp. 543-550
[69.]
S. Lam, J.C. LeRiche, Y. Zheng, A. Coldman, C. McAulay, E. Hawk, et al.
Sex-related differences in bronchial epitelial changes associated with tobacco smoking.
J Natl Cancer Inst, 91 (1999), pp. 691-696
[70.]
S. Lyubsky, M.J. Jacobson.
Lung cancer. Making the diagnosis.
Chest, 100 (1991), pp. 511-520
[71.]
T.C. Kennedy, S.P. Proudfoot, W.A. Franklin, T.A. Merrick, G. Saccomanno, M.E. Corkill, et al.
Cytopathological analysis of sputum in patients with airflow obstruction and significant smoking histories.
Cancer Res, 56 (1996), pp. 4673-4678
[72.]
R.P. Groenendijk, F.A. Croiset van Uchelen, S.J. Mol, D.R. de Munck, A.T. Tan, R.M. Roumen.
Factors related to outcome after pneumonectomy: retrospective study of 62 patients.
Eur J Surg, 165 (1999), pp. 193-197
[73.]
S. Miyoshi, K. Nakahara, K. Ohno, Y. Monden, Y. Kawashima.
Exercise tolerance test in lung cancer patients: the relationship between exercise capacity and postthoracotomy hospital mortality.
Ann Thorac Surg, 44 (1987), pp. 487-490
[74.]
C. Schulz, H.P. Emslander, M. Riedel.
Risk assessment of patients before lung surgery [resumen].
Chirurg, 70 (1999), pp. 664-673
[75.]
H. Bründler, S. Chen, A.P. Perruchoud.
Right heart catheterization in the pre-operative evaluation of patients with lung cancer.
Respiration, 48 (1985), pp. 261-268
[76.]
D. Bechard, L. Wetstein.
Assessment of exercise oxygen consumption as preoperative criterion for lung resection.
Ann Thorac Surg, 44 (1987), pp. 344-349
[77.]
T.P. Smith, G.T. Kinasewitz, W.Y. Tucker, W.P. Spillers, R.B. George.
Exercise capacity as a predictor of post-thoracotomy morbidity.
Am Rev Respir Dis, 129 (1984), pp. 730-734
[78.]
G.N. Olsen, D.S. Weiman, J.W. Bolton, G.D. Gass, W.C. McLain, G.A. Schoonover, et al.
Submaximal invasive exercise testing and quantitative lung scanning in the evaluation for tolerance of lung resection.
Chest, 95 (1989), pp. 267-273
[79.]
R.C. Morice, E.J. Peters, M.B. Ryan, J.B. Putnam, M.K. Ali, J.A. Roth.
Exercise testing in the evaluation of patients at high risk for complications from lung resection.
Chest, 101 (1992), pp. 356-361
[80.]
D.J. Kearney, T.H. Lee, J.J. Reilly, M.M. DeCamp, D.J. Sugarbaker.
Assessment of operative risk in patients undergoing lung resection. Importance of predicted pulmonary function.
Chest, 105 (1994), pp. 753-759
[81.]
J.r. Reilly JJ.
Evidence-based preoperative evaluation of candidates for thoracotomy.
Chest, 116 (1999), pp. S474-S476
[82.]
T.C. Ojo, F. Martínez, I.I.I. Paine R, P.J. Christensen, J.L. Curtis, J.G. Weg, et al.
Lung volume reduction surgery alters management of pulmonary nodules in patients with severe COPD.
Chest, 112 (1997), pp. 1494-1500
[83.]
G.M. Allen, J.r. DewRose JJ.
Pulmonary nodule resection during lung volume reduction surgery [resumen].
Aorn J, 66 (1997), pp. 808-810, 812, 814
[84.]
J.r. McKenna RJ, R.J. Fischel, M. Brenner, A.F. Gelb.
Combined operations for lung volume reduction surgery and lung cancer.
Chest, 110 (1996), pp. 885-888
[85.]
J.r. Miller JI.
Limited resection of bronchogenic carcinoma in the patient with impaired pulmonary function.
Ann Thorac Surg, 56 (1993), pp. 769-771
[86.]
D. Weissberg, C.J. Straehley, N.M. Scully, D.R. Margulies.
Less than lobar resections for bronchogenic carcinoma.
Scand J Thorac Cardiovasc Surg, 27 (1993), pp. 121-126
[87.]
H.A. Shennib, R. Landreneau, D.S. Mulder, M. Mack.
Video-assisted thoracoscopic wedge resection of T1 lung cancer in high-risk patients.
Ann Surg, 218 (1993), pp. 555-558
[88.]
A. Wakabayashi.
Thoracoscopic partial lung resection in patients with severe chronic obstructive pulmonary disease. A preliminary report.
Arch Surg, 129 (1994), pp. 940-943
[89.]
R.J. Korst, R.J. Ginsberg, M. Ailawadi, M.S. Bains, J.r. Downey RJ, V.W. Rusch, et al.
Lobectomy improves ventilatory function in selected patients with severe COPD.
Ann Thorac Surg, 66 (1998), pp. 898-902
[90.]
A. Carretta, P. Zannini, A. Puglisi, G. Chiesa, A. Vanzolli, A. Bianchi.
Improvement of pulmonary function after lobectomy for nonsmall cell lung cancer in emphysematous patients [resumen].
Eur J Cardiothorac Surg, 15 (1999), pp. 602-607
[91.]
H. Berggren, R. Ekroth, G. Malmberg, J. Naucler, G. William-Olsson.
Hospital mortality and long-term survival in relation to preoperative function in elderly patients with bronchogenic carcinoma.
Ann Thorac Surg, 38 (1984), pp. 633-636
[92.]
B.A. Keagy, G.R. Schorlemmer, G.F. Murray, P.J.K. Stareck, B.R. Wilkox.
Correlation of preoperative pulmonary function testing with clinical course in patients after pneumonectomy.
Ann Thorac Surg, 36 (1983), pp. 253-257
Copyright © 2001. Sociedad Española de Neumología y Cirugía Torácica
